Skip to content

Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038002
Enrollment
Unknown
Registered
2020-09-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough variant asthma

Interventions

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Be in line with the diagnostic criteria of cough variant asthma in Modern medicine and the TCM symptoms. 2. Age between 18-65 years old, the disease course is more than 6 weeks. 3. Never taken medicine or have taken the drugs specified in the Guidelines for the Diagnosis and Treatment of Cough (2015). 4. After Stopping the Chinese medicine for CVA for more than two weeks. 5. After stopping the inhalation of corticosteroids, bronchodilators or other drugs to reduce the airway hyperresponsiveness for more than 24 hours, positive bronchodilation test together with cough as the main symptom. 6. Be willing and cooperative with this clinical study, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. With typical asthma, esophageal reflux disease, pharyngitis, etc. 2. Pregnant or lactating women, or be allergic to the drug in this study. 3. Mental disease, behavioral disorder, severe hearing and vision impairments, illiteracy, etc. 4. With severe pulmonary heart disease, respiratory failure or other severe organ dysfunction. 5. Taken other medicines for cough, or being participate in clinical research of other medicines. 6. Poor compliance to treatment.

Design outcomes

Primary

MeasureTime frame
Pulmonary Function;Pulmonary Function;

Countries

China

Contacts

Public ContactTongmao Zhang

The Second Hospital of Tianjin Medical University

13602116692@163.com+86 18602611503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026